Insider · CIK 0001396943

COOPER GRAHAM K

Reports to the SEC for 10 companies · CAMBRIDGE, MA

sec.gov

Transactions

Companies

Filings

CIK

0001396943

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-06-03	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+19.7K sh	—	—	19,676
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−889 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−889 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,500 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,600 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−5,000 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−889 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−3,742 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,600 sh	—	—	0
2026-05-11	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)D Disposition to Issuer	Director	DDisposition to Issuer	−2,600 sh	—	—	0
2025-06-18	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2025-06-04	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+33.7K sh	—	—	33,662
2024-06-20	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+50K sh	—	—	50,000
2024-06-05	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+23.1K sh	—	—	23,114
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,896 sh	—	—	8,896
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,896 sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−8,896 sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)D Disposition to Issuer	Director	DDisposition to Issuer	−26K sh	—	—	0
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,896 sh	—	—	8,896
2023-07-24	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2023-06-15	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+35K sh	—	—	35,000
2023-06-06	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+16.5K sh	—	—	16,532
2022-09-01	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+10.4K sh	—	—	10,391
2022-06-16	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+26K sh	—	—	26,000
2022-05-12	KZRKezar Life Sciences, Inc. · Stock Option (right to buy)A Award	Director	AAward	+26K sh	—	—	26,000
2022-01-27	Applied Molecular Transport Inc.Stock Option (Right to Buy)A Award	Director	AAward	+300K sh	—	—	300,000
2021-07-06	BEAMBeam Therapeutics Inc. · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−2,614 sh	—	—	16,561
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−200 sh	$120.39	−$24.1K	1,300
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−100 sh	$129.38	−$12.9K	0
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−100 sh	$128.67	−$12.9K	100
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−100 sh	$119.68	−$12K	1,500
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−614 sh	$115.38	−$70.8K	2,000
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−100 sh	$126.51	−$12.7K	200
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−300 sh	$124.31	−$37.3K	300
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−200 sh	$118.35	−$23.7K	1,600
2021-07-06	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+2,614 sh	$17.00	+$44.4K	2,614
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−200 sh	$123.76	−$24.8K	600
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−100 sh	$122.85	−$12.3K	800
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−400 sh	$121.59	−$48.6K	900
2021-07-06	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−200 sh	$116.41	−$23.3K	1,800
2021-06-28	KZRKezar Life Sciences, Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+26K sh	—	—	26,000
2021-06-28	BEAMBeam Therapeutics Inc.M Exercise/Conversion	Director	MExercise/Conversion	+12K sh	$17.00	+$205K	12,045
2021-06-28	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−5,787 sh	$105.37	−$610K	6,258
2021-06-28	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−3,196 sh	$106.28	−$340K	3,062
2021-06-28	BEAMBeam Therapeutics Inc.S Sale	Director	SSale	−1,162 sh	$107.22	−$125K	1,900

Recent filings

Accepted (ET)
Jun 54
COOPER GRAHAM K0001193125-26-259519
SEC(opens sec.gov)
May 114
COOPER GRAHAM K0001396943-26-000002
SEC(opens sec.gov)
Jun 234
COOPER GRAHAM K0001415889-25-017967
SEC(opens sec.gov)
Jun 64
COOPER GRAHAM K0000950170-25-083050
SEC(opens sec.gov)
Jun 214
COOPER GRAHAM K0001415889-24-017837
SEC(opens sec.gov)
Jun 74
COOPER GRAHAM K0000950170-24-070783
SEC(opens sec.gov)
Jul 264
COOPER GRAHAM K0001209191-23-043425
SEC(opens sec.gov)

Companies

Address

C/O BEAM THERAPEUTICS INC., 238 MAIN STREET

CAMBRIDGE, MA, 02142